Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. Brahe, Cecilie Heegaard; Ørnbjerg, Lykke Midtbøll; Jacobsson, Lennart; Nissen, Michael John; ... Hetland, Merete Lund 2019
add to browser selection
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration Ørnbjerg, Lykke Midtbøll; Brahe, Cecilie Heegaard; Askling, Johan; Ciurea, Adrian; ... Østergaard, Mikkel 2019
add to browser selection
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Kristianslund, Eirik K; ... Gabay, Cem 2019
add to browser selection
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Klami Kristianslund, Eirik; ... Gabay, Cem 2018
add to browser selection
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Lukina, Galina; Hetland, Merete L; ... van Vollenhoven, Ronald 2017
add to browser selection
The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers Kearsley-Fleet, Lianne; Závada, Jakub; Hetland, Merete Lund; Nordström, Dan C; ... Hyrich, Kimme L 2015